Odyssey
PrivateLast Round
Series D
Sep 10, 2025
Total Funding Raised
$700M
Company Overview
Odyssey Therapeutics is a biotechnology company focused on developing immunomodulators and oncology drugs to enhance drug discovery and expedite clinical development for next-generation precision therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Odyssey Comps
Public and private peers based on sector, stage, and business model.
Odyssey Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2025 | ||||
| IPO Announced | Jan 17, 2025 | ||||
| Series C | Dec 5, 2023 | ||||
| Series B | Oct 13, 2022 | ||||
| Series A | Dec 7, 2021 |
Odyssey Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B |
| CPP Investments | Series C |
| Wedbush Healthcare Partners | Series D |
| KB Investment | Series C |
| Frontline BioVentures | Series B, Series C, Series A |
| KB Investment | Series C |
| Creacion Ventures | Series B, Series C, Series A, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Jolie M. Siegel appointed Executive Vice President, General Counsel.
- Nov 11, 2025
Dennis Dean appointed EVP and Head of Non-Clinical Development.
Odyssey Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Odyssey's valuation, stock price, and market status.
